IGIB scientists develop low cost COVID-19 test; name it after detective character 'Feluda'

Image
Press Trust of India New Delhi
Last Updated : Apr 22 2020 | 4:00 PM IST

Scientists at the CSIR's Institute of Genomics and Integrative Biology have come up with a low-cost coronavirus test that will not require any expensive machines for detection of the pathogen.

Named after 'Feluda', the detective character in legendary filmmaker Satyajit Ray's stories, the test has been developed by Debojyoti Chakraborty and Souvik Maiti as a simpler way of detecting SARS-coV2 presence in clinical samples, IGIB Director Anurag Agarwal said.

CSIR is a department under the Union Ministry of Science and Technology.

It starts the same way as a normal real time reverse transcription- polymerase chain reaction (RT-PCR), which is extraction of ribonucleic acid (RNA) and its conversion to deoxyribonucleic acid (DNA), Agarwal said.

It then differs by using a specifically designed PCR reaction to amplify a part of the viral nucleic acid sequence. Then a highly specific CRISPR, FnCAS9, developed at IGIB, binds to that sequence, he added.

Using the innovative chemistry on a paper strip, the CRISPR complex, bound to that specific sequence, can be visualised as a positive band - like one sees in simple pregnancy tests.

The total time required for the test is less than one hour.

In the RT-PCR tests, the RNA is converted to DNA by using specific primers and probes, with fluorescent reporters, to amplify and detect viral nucleic acid presence. It requires expensive Real Time PCR machines which are available at specialised sites.

"If successfully commercialised, which depends upon all its components being available at scale and the commercial product being successfully validated by regulatory agencies, it would allow the test to be done in local path-labs that do not have expensive real time PCR machines, but simple cheap thermo-blocks used for conventional PCR," Agarwal said.

When asked why the test was named after Feluda, Agarwal said the researchers at MIT and University of California, Berkeley also use CRSIPR, but different technologies.

They have named the tests as 'Detector' and 'Sherlock', so Feluda was an Indian version, he added.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 22 2020 | 4:00 PM IST

Next Story